Adopting the new iStopMM-based criteria for light-chain monoclonal gammopathy of undetermined significance: an ongoing debate
Dor Shpitzer,
Yael C. Cohen,
Tamir Shragai,
Guy Melamed,
Anat Reiner-Benaim,
Irit Avivi
Affiliations
Dor Shpitzer
Department of Epidemiology, Biostatistics and Community Health Sciences, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva
Yael C. Cohen
-Aviv Sourasky (Ichilov) Medical Center and Sackler Faculty of Medicine, Aviv University, Aviv
Tamir Shragai
-Aviv Sourasky (Ichilov) Medical Center and Sackler Faculty of Medicine, Aviv University, Aviv
Guy Melamed
Kahn Sagol Maccabi Research and Innovation Center, Maccabi Healthcare Services, Aviv
Anat Reiner-Benaim
Department of Epidemiology, Biostatistics and Community Health Sciences, School of Public Health, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva
Irit Avivi
-Aviv Sourasky (Ichilov) Medical Center and Sackler Faculty of Medicine, Aviv University, Aviv
